A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Precision BioSciences (DTIL) announced the presentation of preclinical data for its PBGENE-DMD development program for the treatment of ...

Advancements in genome editing, particularly CRISPR, are reshaping precision biology, driving innovations in medicine, agriculture, and synthetic biology.

After hours: March 19 at 7:55:34 PM EDT Loading Chart for MGX ...

EMERYVILLE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company ...

The Diagnostic Specialty Enzymes Market was valued at US$ 1.0 billion in 2022 and is projected to grow at a CAGR of 6.9% from ...

Hemophilia A presentation at American Society of Hematology (ASH) 66th Annual Meeting demonstrated sustained Factor VIII (FVIII) activity in nonhuman primate (NHP) study for more than 16 months ...

Explore the Genome Editing Market size, share, trends, and future growth. Learn about CRISPR, TALENs, ZFNs, and advancements shaping genetic research & medicine.

After hours: March 14 at 7:49:05 p.m. EDT Loading Chart for MGX ...